Table 1.
Baseline characteristics (n = 127).
| No-ESUS and no new AF (n = 73) | New AF (n = 28) | ESUS (n = 26) | p value∗ | |
|---|---|---|---|---|
| Age (years, IQR) | 70 (60–78) | 77 (69–82) | 74 (58–79) | 0.137 |
| Sex (male, %) | 48 (65.8) | 13 (46.4) | 11 (42.3) | 0.157 |
| Arterial hypertension (n, %) | 57 (78.1) | 18 (64.3) | 17 (65.4) | 0.816 |
| Diabetes mellitus (n, %) | 19 (26) | 9 (32.1) | 6 (23.1) | 0.434 |
| Hyperlipidemia (n, %) | 24 (32.9) | 9 (32.1) | 9 (34.6) | 0.807 |
| Smoking (n, %) | 24 (32.9) | 6 (21.4) | 3 (11.5) | 0.122 |
| Heart failure (n, %) | 6 (8.2) | 2 (7.1) | 0 (0) | 0.346 |
| Coronary artery disease (n, %) | 9 (12.3) | 9 (32.1) | 2 (7.7) | 0.019 |
| Peripheral artery disease (n, %) | 1 (1.4) | 2 (7.1) | 1 (3.8) | 0.221 |
| History of ischemic stroke (n, %) | 18 (24.7) | 3 (10.7) | 6 (23.1) | 0.254 |
ESUS: embolic stroke of undetermined source; AF: atrial fibrillation; IQR: interquartile range; ∗ANOVA or Pearson χ2 test as appropriate.